vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and Tradeweb Markets Inc. (TW). Click either name above to swap in a different company.

ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $617.8M, roughly 1.8× Tradeweb Markets Inc.). Tradeweb Markets Inc. runs the higher net margin — 37.7% vs 12.3%, a 25.5% gap on every dollar of revenue. On growth, Tradeweb Markets Inc. posted the faster year-over-year revenue change (21.2% vs 4.8%). ILLUMINA, INC. produced more free cash flow last quarter ($251.0M vs $2.0M). Over the past eight quarters, Tradeweb Markets Inc.'s revenue compounded faster (23.5% CAGR vs -1.3%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Tradeweb Markets Inc., headquartered in New York City, operates electronic trading platforms primarily used by institutional investors to trade fixed income products, ETFs, and derivatives. It has over 3,000 customers including banks, asset managers, central banks, pension funds, and insurance companies. In 2024, 83% of the company's revenue was from transaction fees and commissions and 17% was from subscription fees. In 2024, 52% of revenue came from products related to rates, 27% of revenue...

ILMN vs TW — Head-to-Head

Bigger by revenue
ILMN
ILMN
1.8× larger
ILMN
$1.1B
$617.8M
TW
Growing faster (revenue YoY)
TW
TW
+16.4% gap
TW
21.2%
4.8%
ILMN
Higher net margin
TW
TW
25.5% more per $
TW
37.7%
12.3%
ILMN
More free cash flow
ILMN
ILMN
$249.0M more FCF
ILMN
$251.0M
$2.0M
TW
Faster 2-yr revenue CAGR
TW
TW
Annualised
TW
23.5%
-1.3%
ILMN

Income Statement — Q1 FY2027 vs Q1 FY2026

Metric
ILMN
ILMN
TW
TW
Revenue
$1.1B
$617.8M
Net Profit
$134.0M
$233.2M
Gross Margin
66.1%
Operating Margin
19.2%
46.5%
Net Margin
12.3%
37.7%
Revenue YoY
4.8%
21.2%
Net Profit YoY
38.5%
EPS (diluted)
$0.87
$0.96

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
TW
TW
Q1 26
$1.1B
$617.8M
Q4 25
$1.2B
$521.2M
Q3 25
$508.6M
Q2 25
$513.0M
Q1 25
$509.7M
Q4 24
$1.1B
$463.3M
Q3 24
$1.1B
$448.9M
Q2 24
$1.1B
$405.0M
Net Profit
ILMN
ILMN
TW
TW
Q1 26
$134.0M
$233.2M
Q4 25
$334.0M
$325.0M
Q3 25
$185.6M
Q2 25
$153.8M
Q1 25
$148.4M
Q4 24
$186.0M
$142.2M
Q3 24
$705.0M
$113.9M
Q2 24
$-2.0B
$119.2M
Gross Margin
ILMN
ILMN
TW
TW
Q1 26
66.1%
Q4 25
65.5%
Q3 25
Q2 25
Q1 25
Q4 24
65.9%
Q3 24
69.0%
Q2 24
64.8%
Operating Margin
ILMN
ILMN
TW
TW
Q1 26
19.2%
46.5%
Q4 25
17.4%
42.4%
Q3 25
41.4%
Q2 25
39.0%
Q1 25
40.0%
Q4 24
15.8%
40.7%
Q3 24
68.6%
35.5%
Q2 24
-147.2%
40.1%
Net Margin
ILMN
ILMN
TW
TW
Q1 26
12.3%
37.7%
Q4 25
28.8%
62.4%
Q3 25
36.5%
Q2 25
30.0%
Q1 25
29.1%
Q4 24
16.8%
30.7%
Q3 24
65.3%
25.4%
Q2 24
-178.8%
29.4%
EPS (diluted)
ILMN
ILMN
TW
TW
Q1 26
$0.87
$0.96
Q4 25
$2.16
$1.52
Q3 25
$0.86
Q2 25
$0.71
Q1 25
$0.69
Q4 24
$1.16
$0.66
Q3 24
$4.42
$0.53
Q2 24
$-12.48
$0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
TW
TW
Cash + ST InvestmentsLiquidity on hand
$1.2B
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
Total Assets
$6.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
TW
TW
Q1 26
$1.2B
Q4 25
$1.6B
$2.1B
Q3 25
$1.9B
Q2 25
$1.6B
Q1 25
$1.3B
Q4 24
$93.0M
$1.3B
Q3 24
$70.0M
$1.2B
Q2 24
$74.0M
$1.7B
Stockholders' Equity
ILMN
ILMN
TW
TW
Q1 26
$2.7B
Q4 25
$2.7B
$6.5B
Q3 25
$6.3B
Q2 25
$6.1B
Q1 25
$5.9B
Q4 24
$2.4B
$5.8B
Q3 24
$2.1B
$5.7B
Q2 24
$1.4B
$5.6B
Total Assets
ILMN
ILMN
TW
TW
Q1 26
$6.6B
Q4 25
$6.6B
$8.2B
Q3 25
$8.0B
Q2 25
$8.1B
Q1 25
$7.4B
Q4 24
$6.3B
$7.3B
Q3 24
$6.0B
$7.3B
Q2 24
$6.1B
$7.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
TW
TW
Operating Cash FlowLast quarter
$289.0M
Free Cash FlowOCF − Capex
$251.0M
$2.0M
FCF MarginFCF / Revenue
23.0%
0.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
2.16×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
TW
TW
Q1 26
$289.0M
Q4 25
$321.0M
$355.9M
Q3 25
$342.3M
Q2 25
$409.2M
Q1 25
$60.2M
Q4 24
$364.0M
$282.0M
Q3 24
$316.0M
$292.1M
Q2 24
$80.0M
$285.7M
Free Cash Flow
ILMN
ILMN
TW
TW
Q1 26
$251.0M
$2.0M
Q4 25
$267.0M
$336.5M
Q3 25
$328.3M
Q2 25
$403.7M
Q1 25
$58.6M
Q4 24
$335.0M
$256.8M
Q3 24
$284.0M
$287.8M
Q2 24
$49.0M
$280.8M
FCF Margin
ILMN
ILMN
TW
TW
Q1 26
23.0%
0.3%
Q4 25
23.0%
64.6%
Q3 25
64.5%
Q2 25
78.7%
Q1 25
11.5%
Q4 24
30.3%
55.4%
Q3 24
26.3%
64.1%
Q2 24
4.4%
69.4%
Capex Intensity
ILMN
ILMN
TW
TW
Q1 26
Q4 25
3.7%
Q3 25
2.8%
Q2 25
1.1%
Q1 25
0.3%
Q4 24
2.6%
5.4%
Q3 24
3.0%
1.0%
Q2 24
2.8%
1.2%
Cash Conversion
ILMN
ILMN
TW
TW
Q1 26
2.16×
Q4 25
0.96×
1.10×
Q3 25
1.84×
Q2 25
2.66×
Q1 25
0.41×
Q4 24
1.96×
1.98×
Q3 24
0.45×
2.56×
Q2 24
2.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

TW
TW

Transaction fees and commissions$523.8M85%
Subscription fees$60.3M10%
LSEG market data fees$26.7M4%

Related Comparisons